Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Sheehan

Showing results (71-80 of 195) with videos related to

Pageof 20
Sort By:
Plos One|January 6, 2011
A quantitative, non-destructive methodology for habitat characterisation and benthic monitoring at offshore renewable energy developmentsEmma V Sheehan, Timothy F Stevens, Martin J Attrill
Innovations in Clinical Neuroscience|December 19, 2014
The Columbia-Suicide Severity Rating Scale (C-SSRS): Has the "Gold Standard" Become a Liability?Jennifer M Giddens, Kathy Harnett Sheehan, David V Sheehan
Acta Psychiatrica Scandinavica|May 1, 1986
Dental anxiety--the development of a measurement modelA A Weiner, D V Sheehan, K J Jones
Innovations in Clinical Neuroscience|December 19, 2014
Current Assessment and Classification of Suicidal Phenomena using the FDA 2012 Draft Guidance Document on Suicide Assessment: A Critical ReviewDavid V Sheehan, Jennifer M Giddens, Kathy Harnett Sheehan
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1990
A double-blind comparison of fluvoxamine, desipramine and placebo in outpatients with depressionD Roth, J Mattes, K H Sheehan, et al.
Journal of Affective Disorders|October 19, 2013
Effects of extended-release quetiapine fumarate on long-term functioning and sleep quality in patients with Generalized Anxiety Disorder (GAD): data from a randomized-withdrawal, placebo-controlled maintenance studyDavid V Sheehan, Henrik Svedsäter, Julie C Locklear, et al.
P & T : a Peer-Reviewed Journal for Formulary Management|September 17, 2010
Expenditures associated with dose titration at initiation of therapy in patients with major depressive disorder: a retrospective analysis of a large managed care claims databaseFabian Camacho, Meg C Kong, David V Sheehan, et al.
Innovations in Clinical Neuroscience|June 4, 2011
The use of research measures in adult clinical practiceJoan Busner, Stuart L Kaplan, Nicholas Greco, et al.
Psychopharmacology Bulletin|June 29, 2010
The efficacy and tolerability of once-daily controlled-release trazodone for depressed mood, anxiety, insomnia, and suicidality in major depressive disorderDavid V Sheehan, Anna Rozova, E Roderich Gossen, et al.
The International Journal of Clinical and Experimental Hypnosis|July 1, 1986
A three-year follow-up of hypnosis and restricted environmental stimulation therapy for smokingA F Barabasz, L Baer, D V Sheehan, et al.
Pageof 20

Showing results (71-80 of 195) with videos related to

Sort By:
Pageof 20
Plos One|January 6, 2011
A quantitative, non-destructive methodology for habitat characterisation and benthic monitoring at offshore renewable energy developmentsEmma V Sheehan, Timothy F Stevens, Martin J Attrill
Innovations in Clinical Neuroscience|December 19, 2014
The Columbia-Suicide Severity Rating Scale (C-SSRS): Has the "Gold Standard" Become a Liability?Jennifer M Giddens, Kathy Harnett Sheehan, David V Sheehan
Acta Psychiatrica Scandinavica|May 1, 1986
Dental anxiety--the development of a measurement modelA A Weiner, D V Sheehan, K J Jones
Innovations in Clinical Neuroscience|December 19, 2014
Current Assessment and Classification of Suicidal Phenomena using the FDA 2012 Draft Guidance Document on Suicide Assessment: A Critical ReviewDavid V Sheehan, Jennifer M Giddens, Kathy Harnett Sheehan
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1990
A double-blind comparison of fluvoxamine, desipramine and placebo in outpatients with depressionD Roth, J Mattes, K H Sheehan, et al.
Journal of Affective Disorders|October 19, 2013
Effects of extended-release quetiapine fumarate on long-term functioning and sleep quality in patients with Generalized Anxiety Disorder (GAD): data from a randomized-withdrawal, placebo-controlled maintenance studyDavid V Sheehan, Henrik Svedsäter, Julie C Locklear, et al.
P & T : a Peer-Reviewed Journal for Formulary Management|September 17, 2010
Expenditures associated with dose titration at initiation of therapy in patients with major depressive disorder: a retrospective analysis of a large managed care claims databaseFabian Camacho, Meg C Kong, David V Sheehan, et al.
Innovations in Clinical Neuroscience|June 4, 2011
The use of research measures in adult clinical practiceJoan Busner, Stuart L Kaplan, Nicholas Greco, et al.
Psychopharmacology Bulletin|June 29, 2010
The efficacy and tolerability of once-daily controlled-release trazodone for depressed mood, anxiety, insomnia, and suicidality in major depressive disorderDavid V Sheehan, Anna Rozova, E Roderich Gossen, et al.
The International Journal of Clinical and Experimental Hypnosis|July 1, 1986
A three-year follow-up of hypnosis and restricted environmental stimulation therapy for smokingA F Barabasz, L Baer, D V Sheehan, et al.
Pageof 20